- JP-listed companies
- J-Pharma Co.,Ltd.
- Balance sheet
J-Pharma Co.,Ltd. (520A) Balance sheet
Market cap
¥6.7B
P/E ratio
-2.4x
J-Pharma develops innovative small-molecule drugs targeting LAT1 transporters to treat cancer and autoimmune diseases with novel mechanisms of action.
| 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Cash and cash equivalents | - | 1,073 | 2,302 | 4,452 |
| Marketable securities, current | - | - | - | 1 |
| Total current assets | - | 1,190 | 2,839 | 4,753 |
| Total non-current assets | - | 18 | 18 | 8 |
| Total assets | - | 1,207 | 2,857 | 4,761 |
| Total current liabilities | - | 200 | 452 | 378 |
| Total non-current liabilities | - | 58 | 27 | 5 |
| Total liabilities | - | 257 | 479 | 383 |
| Retained earnings | - | -1,652 | -1,499 | -2,466 |
| Stockholders' equity | 1,408 | 950 | 2,378 | 4,378 |